DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ADULTS

Authors
  • Galiulin Talgat Izilevich

    Assistant the Department of Infectious Diseases, Pediatric Infectious Diseases, Phthisiology and Pulmonology at Tashkent State Medical University Organization - Tashkent State Medical University, Republican Specialized Scientific Medical Practical Center of Phthisiology and the Monologue Pool named after Sh. Alimov

    Author

Keywords:
Latent tuberculosis infection, tuberculosis, diagnosis, tuberculin skin test, interferon-gamma release assay, adults.
Abstract

Latent tuberculosis infection (LTBI) remains a significant global public health concern. Approximately one-quarter of the world's population is estimated to be infected with Mycobacterium tuberculosis, with most individuals harboring the bacteria in a latent state. Although these individuals do not exhibit symptoms and are not contagious, they remain at risk of developing active tuberculosis (TB) disease during their lifetime. Early diagnosis of LTBI is essential for preventing disease progression and reducing TB transmission. This article reviews the epidemiology, risk factors, diagnostic methods, advantages and limitations of available tests, and current recommendations for diagnosing latent tuberculosis infection in adults.

References

1.Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., et al. (2016). Tuberculosis. Nature Reviews Disease Primers, 2(1), Article 16076, pp. 1–23. https://doi.org/10.1038/nrdp.2016.76

2.Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., et al. (2015). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, 46(6), pp. 1563–1576. https://doi.org/10.1183/13993003.01245-2015

3.Sterling, T. R., Njie, G., Zenner, D., Cohn, D. L., Reves, R., Ahmed, A., et al. (2020). Guidelines for the treatment of latent tuberculosis infection. Clinical Infectious Diseases, 63(7), pp. e147–e195. https://doi.org/10.1093/cid/ciw778

4.Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., et al. (2017). Official American Thoracic Society/Infectious Diseases Society of America/CDC Clinical Practice Guidelines: Diagnosis of tuberculosis in adults and children. Clinical Infectious Diseases, 64(2), pp. 111–115. https://doi.org/10.1093/cid/ciw694

5.Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., et al. (2009). LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. European Respiratory Journal, 33(5), pp. 956–973.

6.World Health Organization. (2024). Global Tuberculosis Report 2024. Geneva: World Health Organization, pp. 1–214.

7.World Health Organization. (2020). WHO Consolidated Guidelines on Tuberculosis: Module 1 – Prevention. Geneva: World Health Organization, pp. 1–112.

8.Centers for Disease Control and Prevention. (2024). Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. Atlanta, GA: CDC, pp. 1–54.

9.European Centre for Disease Prevention and Control. (2023). Programmatic Management of Latent Tuberculosis Infection in the European Union. Stockholm: ECDC, pp. 1–82.

10.Rangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D. I., Menzies, D., Mwansa-Kambafwile, J., et al. (2012). Predictive value of interferon-gamma release assays for incident active tuberculosis: A systematic review and meta-analysis. The Lancet Infectious Diseases, 12(1), pp. 45–55.

Downloads
Published
2026-06-04
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ADULTS. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(5), 406-416. https://eurekaoa.com/index.php/5/article/view/1128